From Yahoo Finance: 2025-06-06 12:13:00

Omada Health goes public with an IPO valued at $1.1 billion, following Hinge Health’s success. Trading at $23 per share, the stock hit $28 midday. Omada focuses on clinical health guidance for chronic diseases and weight loss management. CEO Duffy highlights the company’s differentiation in the market.
Omada’s growth, spotlighted by the pandemic, stems from partnerships with large companies and pharmacy benefit managers. The company started by serving diabetics and expanded into the GLP-1 market. Despite not yet turning a profit in its 14-year history, Omada’s losses are decreasing as revenue grows yearly.
With net losses of $67.5 million in 2023 and $47.1 million in 2024, Omada aims for profitability. CEO Duffy looks to new investors to guide the company towards becoming a leading chronic disease platform. Anjalee Khemlani covers Omada’s journey as a senior health reporter at Yahoo Finance.

Read more: Omada Health goes public at $23 per share, marking second digital health IPO in 2025